XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock, Common [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2022 146,426,697   41,309    
Balance at Dec. 31, 2022 $ 146 $ 1,623,924 $ (234) $ (1,565,249) $ 58,587
Issuance of common stock in connection with exercise of options (in shares) 66,701   0    
Issuance of common stock in connection with exercise of options   363 $ 0 0 363
Issuance of restricted stock (in shares) 3,017,736   0    
Issuance of restricted stock $ 3 (3) $ 0 0 0
Warrants issued with debt financing $ 0 595 $ 0 0 595
Forfeiture of restricted stock (in shares) (73,787)   0    
Forfeiture of restricted stock     $ 0 0 0
Compensation in respect of restricted stock granted to employees, directors and consultants $ 0 7,120 0 0 7,120
Net loss $ 0 0 $ 0 (39,232) (39,232)
Balance (in shares) at Mar. 31, 2023 149,437,347   41,309    
Balance at Mar. 31, 2023 $ 149 1,631,999 $ (234) (1,604,481) 27,433
Balance (in shares) at Dec. 31, 2022 146,426,697   41,309    
Balance at Dec. 31, 2022 $ 146 1,623,924 $ (234) (1,565,249) 58,587
Net loss         (86,841)
Balance (in shares) at Jun. 30, 2023 150,969,323   41,309    
Balance at Jun. 30, 2023 $ 151 1,692,627 $ (234) (1,652,091) 40,453
Balance (in shares) at Mar. 31, 2023 149,437,347   41,309    
Balance at Mar. 31, 2023 $ 149 1,631,999 $ (234) (1,604,481) 27,433
Issuance of common stock in connection with exercise of options (in shares) 76,955   0    
Issuance of common stock in connection with exercise of options   751 $ 0 0 751
Issuance of restricted stock (in shares) 95,000   0    
Issuance of restricted stock     $ 0 0 0
Forfeiture of restricted stock (in shares) (25,679)   0    
Forfeiture of restricted stock     $ 0 0 0
Compensation in respect of restricted stock granted to employees, directors and consultants $ 0 13,582 0 0 13,582
Net loss $ 0 0 $ 0 (47,610) (47,610)
Issuance of common stock in public offering (net of offering costs of $0.8 million) (in shares) 1,385,700        
Issuance of common stock in public offering (net of offering costs of $0.8 million) $ 2 46,295   46,297
Balance (in shares) at Jun. 30, 2023 150,969,323   41,309    
Balance at Jun. 30, 2023 $ 151 1,692,627 $ (234) (1,652,091) 40,453
Balance (in shares) at Dec. 31, 2023 151,465,598   41,309    
Balance at Dec. 31, 2023 $ 151 1,713,162 $ (234) (1,552,577) 160,502 [1]
Issuance of common stock in connection with exercise of options (in shares) 2,500   0    
Issuance of common stock in connection with exercise of options   10 $ 0 0 10
Issuance of restricted stock (in shares) 3,304,468   0    
Issuance of restricted stock $ 4 (4) $ 0 0 0
Forfeiture of restricted stock (in shares) (165,514)   0    
Forfeiture of restricted stock     $ 0 0 0
Compensation in respect of restricted stock granted to employees, directors and consultants $ 0 10,304 0 0 10,304
Net loss $ 0 $ 0 (10,707) (10,707)
Balance (in shares) at Mar. 31, 2024 154,607,052   41,309    
Balance at Mar. 31, 2024 $ 155 1,723,472 $ (234) (1,563,284) 160,109
Balance (in shares) at Dec. 31, 2023 151,465,598   41,309    
Balance at Dec. 31, 2023 $ 151 1,713,162 $ (234) (1,552,577) $ 160,502 [1]
Issuance of common stock in connection with exercise of options (in shares)         29,750
Net loss         $ (3,828)
Balance (in shares) at Jun. 30, 2024 154,873,847   41,309    
Balance at Jun. 30, 2024 $ 155 1,734,052 $ (234) (1,556,405) 177,568
Balance (in shares) at Mar. 31, 2024 154,607,052   41,309    
Balance at Mar. 31, 2024 $ 155 1,723,472 $ (234) (1,563,284) 160,109
Issuance of common stock in connection with exercise of options (in shares) 27,250   0    
Issuance of common stock in connection with exercise of options   135 $ 0 0 135
Issuance of restricted stock (in shares) 332,138   0    
Issuance of restricted stock     $ 0 0 0
Forfeiture of restricted stock (in shares) (92,593)   0    
Forfeiture of restricted stock     $ 0 0 0
Compensation in respect of restricted stock granted to employees, directors and consultants $ 0 10,445 0 0 10,445
Net loss $ 0 $ 0 6,879 6,879
Balance (in shares) at Jun. 30, 2024 154,873,847   41,309    
Balance at Jun. 30, 2024 $ 155 $ 1,734,052 $ (234) $ (1,556,405) $ 177,568
[1] Amounts as of December 31, 2023 have been reclassified to conform to current period presentation.